Diagnostics (Basel, Switzerland)
Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Diagnostics 2025, 15, 2126.
Gianluca Pagnoni, Aurora Vicenzi, Francesca Coppi
Published: 202510.3390/diagnostics16010055
Abstract
Open AccessWe read with interest the work by Iancu et al [...].